From moulding to medical device manufacturing

Inzign started out specialising in mould making, and evolved into a biomedical device contract manufacturer.

Published on 30 Apr 2024


The transformation involved a collaboration with NYP, with both partners tapping on each other’s strengths to achieve objectives.

While the company contributed their knowledge in processes and production, NYP employed its strength in robotics, automation and manufacturing technology. We carried out conceptualisation and qualifications for design, installation and operations, as well as factory and site acceptance tests for GMP conformity – and the company received FDA approval for their business production.


Image shows capabilities in NYP's Centre for Digital & Precision Engineering